Sellas Life Sciences has reported the multicentre Phase IIa trial data of a highly selective cyclin-dependent kinase 9 (CDK9) ...
Origin Materials has commenced the commercial production of polyethylene terephthalate (PET) caps at its manufacturing centre ...